Crossmark

Transbronchial lung cryobiopsy for interstitial lung disease: early experience, learning curve, and the impact of sedation on complication rates at a single centre in Japan

Crossref DOI link: https://doi.org/10.1186/s12890-024-03359-1

Published Online: 2024-10-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kaburaki, Shota

Tanaka, Toru

Kamio, Koichiro

Tanaka, Yosuke

Kasahara, Kazuo

Seike, Masahiro
License Information

Text and Data Mining valid from 2024-10-29

Version of Record valid from 2024-10-29
More Information

Article History

Received: 11 August 2024

Accepted: 21 October 2024

First Online: 29 October 2024

Declarations

:

: The authors declare no competing interests.

: None of the authors has a conflict of interest to declare.

: The Nippon Medical School Hospital Institutional Review Board approved this study (approval number B-2024-875) and waived informed consent due to its retrospective nature. Clinical trial number: not applicable. This study was conducted in accordance with the principles of the Declaration of Helsinki.

: Informed consent was waived by the Nippon Medical School Hospital Institutional Review Board due to the retrospective nature of this study.

: Clinical trial number: not applicable.

Document is current

Any future updates will be listed below